<code id='433500E577'></code><style id='433500E577'></style>
    • <acronym id='433500E577'></acronym>
      <center id='433500E577'><center id='433500E577'><tfoot id='433500E577'></tfoot></center><abbr id='433500E577'><dir id='433500E577'><tfoot id='433500E577'></tfoot><noframes id='433500E577'>

    • <optgroup id='433500E577'><strike id='433500E577'><sup id='433500E577'></sup></strike><code id='433500E577'></code></optgroup>
        1. <b id='433500E577'><label id='433500E577'><select id='433500E577'><dt id='433500E577'><span id='433500E577'></span></dt></select></label></b><u id='433500E577'></u>
          <i id='433500E577'><strike id='433500E577'><tt id='433500E577'><pre id='433500E577'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:79379
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Fauci's latest grilling in Congress: 9 hours, behind closed doors
          Fauci's latest grilling in Congress: 9 hours, behind closed doors

          AnthonyFaucispentninehoursonCapitolHillyesterday,talkingCovidbehindcloseddoors—andthatwasjustdayone.

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          American taxpayers paid $1.8 trillion in health care costs in 2022

          AdobeAmericantaxpayersfootedthebillforatleast$1.8trillioninfederalandstatehealthcareexpendituresin20